META vs TMO: Which Is the Better Buy?
Side-by-side comparison of Meta Platforms, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Meta Platforms, Inc. · Communication Services
$671.34
+117.9% upside to fair value
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
META has more upside to fair value
(+117.9%).
TMO trades at a lower forward P/E
(25.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
META |
TMO |
| Current Price |
$671.34 |
$462.60 |
| Fair Value Estimate |
$1,463.17 |
$509.20 |
| Upside to Fair Value |
+117.9%
|
+10.1%
|
| Market Cap |
$1,698.2B |
$171.9B |
| Forward P/E |
28.0x
|
25.1x
|
| EV / EBITDA |
16.5x
|
19.0x
|
| Price / Sales |
8.4x
|
3.8x
|
| Price / FCF |
36.8x
|
25.5x
|
| Revenue Growth YoY |
+23.8%
|
+6.2%
|
| Gross Margin |
82.0%
|
39.4%
|
| Operating Margin |
41.4%
|
17.8%
|
| Return on Equity |
30.6%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.72%
|
3.92%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Meta Platforms, Inc. operates a leading global social media and technology platform primarily through its Family of Apps segment, which generates over 98% of its $201 billion 2025 revenue, driven by strong advertising growth. The company maintains a high-quality business with a durable competitive moat supported by network effects, brand strength, and intangible assets, reflected in a 30.6% retur…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
META |
TMO |
| Zone Low |
$1,097.38 |
$381.90 |
| Zone High |
$1,243.69 |
$432.82 |
| In Buy Zone? |
Yes
|
No
|